FibroGen, Inc. Stock price
Is FibroGen, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,134 stocks worldwide.
Key metrics
FibroGen, Inc. Stock Analysis
Analyst Opinions
8 Analysts have issued a FibroGen, Inc. forecast:
Analyst Opinions
8 Analysts have issued a FibroGen, Inc. forecast:
Don't miss a Thing! We will send you all news about FibroGen, Inc. directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993 and is headquartered in San Francisco, CA.
| Head office | United States |
| CEO | Mr. Wettig |
| Employees | 225 |
| Founded | 1993 |
| Website | www.fibrogen.com |


